Health
Male bladder cancer vulnerability could be exploited to design new therapeutic strategies – News-Medical.Net
A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer.
A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer. A multi-institution study led by UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors – a type of protein that is crucial for the function of testosterone – may destroy cancer cells.
The study, published in the April 28, 2021 issue of Cancer Letters is important because, for the first time, it showed that a newly identified form of the protein is commonly…
-
Business17 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News14 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business18 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business14 hours ago1 ASX dividend stock down 43% I’d buy right now